Role of COL6A2 in malignant progression and temozolomide resistance of glioma
Authors:
- Xia HongXHXia Hong
- Jingjing ZhangJZJingjing Zhang
- Jianmin ZouJZJianmin Zou
- Jiecai OuyangJOJiecai Ouyang
- Boan XiaoBXBoan Xiao
- Peng WangPWPeng Wang
- Xiaobin PengXPXiaobin Peng
- 12 December 2022
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 102
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- COL6A3 Protein Deficiency in Mice Leads to Muscle and Tendon Defects Similar to Human Collagen VI Congenital Muscular DystrophyJournal of Biological Chemistry, 2013
- Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumoursEMBO Molecular Medicine, 2013
- Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathwayCellular Signalling, 2012
- Collagen VI Ablation Retards Brain Tumor Progression Due to Deficits in Assembly of the Vascular Basal LaminaThe American Journal of Pathology, 2012
- Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisionsCell Death & Disease, 2011
- Epidemiology and molecular pathology of gliomaNature Clinical Practice Neurology, 2006
- Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op miceJournal of Leukocyte Biology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Identification of human brain tumour initiating cellsNature, 2004
- Distribution of Type VI Collagen in Human GliomasJournal of Neuropathology & Experimental Neurology, 1987